Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
c.IVS40-2A>G (c.5066-2A>G) | Heterozygous | Mutation |
wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
GAT | Asp | spl-2 | Spl. | A->G | Ts |
Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
TGFBP#05 | conserved AA in TGFBP |
At the mRNA level | On restriction map |
Not tested on cDNA | New restriction site(s): none Lost restriction site(s): none |
Impact on splicing | ||||||||||
Splice site type | Wild type sequence | CV | Mutant type sequence | CV | Variation (%) | |||||
cctcccttctagAT |
| cctcccttctggAT |
| -34.4 % |
Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
ITA02PAV F0053 I01 | Proband | NA | NA | ITALIA |
Phenotypic group | Disease |
NA | Classical MFS |
Symptom |
Reference ID | PubMed ID | Reference |
125 | 16222657 | Arbustini E, Grasso M, Ansaldi S, Malattia C, Pilotto A, Porcu E, Disabella E, Marziliano N, Pisani A, Lanzarini L, Mannarino S, Larizza D, Mosconi M, Antoniazzi E, Zoia MC, Meloni G, Magrassi L, Brega A, Bedeschi MF, Torrente I, Mari F, Tavazzi L. "Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies". Hum Mutat. 2005 Nov;26(5):494. |